Related Experiment Video
Updated: Oct 9, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Parkinsonism in patients with vascular dementia: clinical, computed- and positron emission-tomographic findings
1Department of Neurology, University Hospital, Ghent University, Ghent, Belgium. jdereuck@yucom.be
Purpose:
The present study investigates the vascular nature of parkinsonian features in patients with 'probable' vascular dementia.
Patients And Methods:
Forty patients with vascular dementia were studied with positron emission tomography (PET) using the steady state technique with (15)O in order to assess regional cerebral blood flow (rCBF), regional oxygen extraction rate (rOER) and regional metabolic rate for oxygen (rCMRO(2)) in different brain regions. The findings in 10 patients with (VaDP) were compared to 30 without parkinsonism (VaD).
Results:
The clinical and computed tomographic findings in the parkinsonian patients were similar to those described in the literature as probable vascular parkinsonism. The PET results showed decreased rCBF and rCMRO(2) in the frontal and parietal cortices and in the striatum of the VaDP compared to the VaD group. The decrease of rCBF and rCMRO(2) in frontal and parietal cortices is due to the more severe mental changes in the VaDP group. In the VaDP patients rCBF and rCMRO(2) were more decreased and rOER increased in the striatum contralateral to the most affected parkinsonian side.
Conclusion:
Our PET findings show that local ischemic changes in the striatum contribute to parkinsonism in vascular dementia patients.
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Parkinson Disease ll: Pathophysiology
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
